Edwards Lifesciences (EW) Announces Sale of TMR Heart Laser Distribution Rights to Novadaq
Edwards Lifesciences Corporation (NYSE: EW) has sold the exclusive U.S. distribution rights and the inventory associated with Edwards' transmyocardial revascularization (TMR) laser product line to Novadaq Technologies Inc. The TMR system is manufactured by PLC Medical Systems (Amex: PLC).
Total consideration for this sale is estimated to be between $8-9 million, which includes the purchase of inventory valued at approximately $1.4 million and an earn-out based on 2007 sales. This transaction will result in a slight gain in the first quarter and Edwards will record income from the earn-out during the remainder of 2007. The company does not expect this transaction to have a material impact on its 2007 earnings guidance.
Total consideration for this sale is estimated to be between $8-9 million, which includes the purchase of inventory valued at approximately $1.4 million and an earn-out based on 2007 sales. This transaction will result in a slight gain in the first quarter and Edwards will record income from the earn-out during the remainder of 2007. The company does not expect this transaction to have a material impact on its 2007 earnings guidance.
You May Also Be Interested In
- UPDATE: SAP's (SAP) America Unit to Buy Ariba (ARBA) for $45/Share
- UPDATE: RR Donnelley (RRD) to Buy Edgar Online (EDGR) for $70.5M
- China Investment may nab $2B stake in Alibaba - Reuters
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
